Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Saved in:
Bibliographic Details
Title: Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Authors: Ng J; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Cai L; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.; Children's Research Institute, UT Southwestern Medical Center, Dallas, Texas.; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas., Girard L; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas., Prall OWJ; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Rajan N; Department of Anatomical Pathology, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Khoo C; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Batrouney A; Department of Anatomical Pathology, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Byrne DJ; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Boyd DK; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Kersbergen AJ; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Christie M; Department of Anatomical Pathology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Minna JD; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.; Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas., Burr ML; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.; Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, Australian Capital Territory, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Sutherland KD; ACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1846-1858.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-23-2360